Literature DB >> 2591598

Large corneal grafts can be successful.

C M Kirkness1, L A Ficker, N S Rice, A D Steele.   

Abstract

Seventeen grafts of 10 mm in diameter or larger have been performed on 16 eyes of 15 patients. The major indications for surgery were infections or perforations or both. Follow-up has ranged from 8-54 months (mean 26.4). The 4 year survival probability was 0.64. Although the procedure was successful in saving all but one eye and restored useful vision in the majority, complications including cataract, glaucoma, graft rejection episodes and infections were encountered. The management of these complications is described. At final review, 13 eyes had clear grafts including those in whom regraft had been performed. These results have only been achieved by close co-operation between patients and the medical team responsible for their care.

Entities:  

Mesh:

Year:  1989        PMID: 2591598     DOI: 10.1038/eye.1989.7

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  4 in total

1.  A Two-Piece Microkeratome-Assisted Mushroom Keratoplasty Improves the Outcomes and Survival of Grafts Performed in Eyes with Diseased Stroma and Healthy Endothelium (An American Ophthalmological Society Thesis).

Authors:  Massimo Busin; Silvana Madi; Vincenzo Scorcia; Paolo Santorum; Yoav Nahum
Journal:  Trans Am Ophthalmol Soc       Date:  2015

2.  Simultaneous Vitreoretinal Surgery and Sclerokeratoplasty for Keratoglobus with Intraocular Hemorrhage and Extensive Corneal Rupture.

Authors:  Fumiaki Higashijima; Ren Aoki; Masanori Mikuni; Takuya Yoshimoto; Nanako Iwamoto; Manami Ohta; Tadahiko Ogata; Naoyuki Yamada; Kazuhiro Kimura
Journal:  Case Rep Ophthalmol       Date:  2022-03-24

3.  Corneoscleral transplantation for end stage corneal disease.

Authors:  L W Hirst; G A Lee
Journal:  Br J Ophthalmol       Date:  1998-11       Impact factor: 4.638

4.  Outcome of Sclerokeratoplasty in Devastating Sclerocorneal Infections.

Authors:  Shreya Thatte; Ankita B Dube; Trupti Dubey; Malvika Krishnan
Journal:  J Curr Ophthalmol       Date:  2020-03-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.